The red cell transfusion trigger: has a sin of commission now become a sin of omission?

Transfusion
C R ValeriJ Loscalzo

Abstract

The benefits of a Hct range of 30 to 35 percent include improved oxygen delivery and enhanced hemostasis, which help minimize complications in patients at high risk for ischemia and perioperative nonsurgical bleeding. In these settings, the conservative transfusion practice of using a lower Hct range should be replaced with a more aggressive approach. The known risks of blood transfusion would appear to be sufficiently low and the benefits sufficiently high to justify maintaining a Hct of at least 30 percent. An even higher Hct, of 35 percent, may be desirable in patients who have overt cardiopulmonary disease or who are at high risk for myocardial ischemia. Many retrospective studies have been conducted to persuade us that a conservative transfusion trigger is a safe and prudent practice, but retrospective studies are not what we need. What we need is a series of well-designed, prospective, randomized trials to evaluate the impact of a more aggressive transfusion policy on perioperative mortality, morbidity, and nonsurgical bleeding in patients with known cardiopulmonary disease or who are at high risk for myocardial and cerebrovascular ischemia.

Citations

Jun 1, 2005·Anesthesiology Clinics of North America·B Craig Weldon
Jun 16, 2005·Burns : Journal of the International Society for Burn Injuries·Michael S O'MaraPhilip F Caushaj
May 1, 2001·British Journal of Haematology·M F MurphyUNKNOWN British Committee for Standards in Haematology, Blood Transfusion Task Force
Apr 23, 2002·Transfusion Medicine·J P WallisD B L McClelland
Sep 12, 2001·Transfusion·M RiosM E Reid
Jan 10, 2003·Transfusion·Marion E Reid
Feb 11, 1999·The New England Journal of Medicine·L T GoodnoughJ P AuBuchon
Jul 17, 1999·The New England Journal of Medicine·C R ValeriJ P Crowley
Apr 18, 2006·Critical Care Medicine·Jean-Louis Vincent, Michael Piagnerelli
Oct 28, 2003·Annals of Surgery·David H LivingstonPranela Rameshwar
Dec 24, 2005·The Journal of Trauma·Dan DrobinRobert G Hahn
Mar 6, 2003·Vox Sanguinis·Lawrence Tim Goodnough
Mar 6, 2003·Vox Sanguinis·Lorna M Williamson
Jan 8, 2013·Journal of Burn Care & Research : Official Publication of the American Burn Association·K N WilliamsK Muthumalaiappan
Oct 3, 2002·Anesthesiology·Richard B Weiskopf
Dec 3, 2002·Anesthesiology·Donat R SpahnUNKNOWN European Perflubron Emulsion in Non-Cardiac Surgery Study Group
Oct 29, 2008·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·C R Valeri, G Ragno
Dec 1, 2004·Microscopy Research and Technique·Thomas H FischerMark H Schoenfisch
Jun 24, 2008·Microscopy Research and Technique·Carr J SmithThomas H Fischer
Feb 9, 2011·Paediatric Anaesthesia·Romain JouffroyGilles Orliaguet
Sep 2, 2006·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·C Robert Valeri, Gina Ragno
Jun 8, 2017·British Journal of Haematology·Marlijn P A HoeksJaap-Jan Zwaginga
Aug 9, 2001·British Journal of Anaesthesia·B M IselinD R Spahn
May 12, 2020·Clinical Hemorheology and Microcirculation·U WindbergerH Lichtenegger
Aug 31, 1999·The Journal of Bone and Joint Surgery. American Volume·M S KennedyD Krugh
Jan 26, 1999·Clinical Orthopaedics and Related Research·R K Spence
Mar 15, 2001·American Journal of Physiology. Heart and Circulatory Physiology·J W HortonB Sanders
Mar 6, 2003·Vox Sanguinis·Lawrence Tim Goodnough

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.